Carnegie Capital Asset Management, LLC Maravai Lifesciences Holdings, Inc. Transaction History

Carnegie Capital Asset Management, LLC

  • $3.34 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 11, 2022
SELL
$24.46 - $40.92 $645,499 - $1.08 Million
-26,390 Closed
0 $0
Q4 2021

Jan 21, 2022
BUY
$35.0 - $45.94 $483,350 - $634,431
13,810 Added 109.78%
26,390 $1.11 Million
Q3 2021

Oct 08, 2021
BUY
$36.8 - $60.62 $462,943 - $762,599
12,580 New
12,580 $617,000

Others Institutions Holding MRVI

# of Institutions
234
Shares Held
140M
Call Options Held
223K
Put Options Held
19.4K
View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

MRVI Quotes by TradingView
  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $706M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Carnegie Capital Asset Management, LLC Portfolio

Follow Carnegie Capital Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carnegie Capital Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carnegie Capital Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email